Genus Polskasp. z o.o.

Pre-primary education

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-09-20
Share capital
10,050.00 PLN
Registered address
ul. Jerzego Bajana 8, 31-520 Kraków, Poland
Electronic delivery address
AE:PL-98768-83587-WHTGD-29

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 24 days late).

  • 202506/07/2026
  • 202427/06/2025
  • 202327/06/2024
  • 202213/07/2023
  • 202108/08/2022
  • 202024/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 542.08kMedianUSD 519.42kAverageUSD 813.31k
Net profit
This companyUSD 230.00MedianUSD 8.09kAverageUSD 35.19k
Operating costs
This companyUSD 541.64kMedianUSD 453.55kAverageUSD 725.01k
Assets
This companyUSD 13.52kMedianUSD 80.92kAverageUSD 253.61k

Industry

Authorized Representatives

Adam Jan Krusenstern – Vice President of the Management Board
Tomasz Maria Kwinta – President of the Management Board

Manner of representation

The company is represented by: A) one member of the management board independently – for transactions whose one-off value does not exceed PLN 100,000; B) two members of the management board jointly – for transactions whose one-off value exceeds PLN 100,000.

Ownership

OwnerSharesShare valueStake
Adam Jan Krusensternage 51
29$391.6814.4279%
Tomasz Maria Kwintaage 63
172$2,323.0785.5721%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $13,303.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,708
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,842
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,830

Competitors

FAQ

Last updated: 2026-07-09